So-Young Intl Stock Price, News & Analysis

So-Young International Inc. (NASDAQ: SY) will release its financial results for Q4 and the full year ended December 31, 2021, on March 25, 2022, before U.S. markets open. The company is the leading social community in China's medical aesthetics sector, offering trustworthy content and a platform that connects consumers with vetted service providers. With a strong brand image and engaging community, So-Young aims to expand in both the medical aesthetics and fast-growing healthcare service markets.

So-Young International Inc. (Nasdaq: SY) announced that its board's special committee has engaged Duff & Phelps and Gibson, Dunn & Crutcher LLP to evaluate a non-binding proposal from CEO Xing Jin. The offer proposes to acquire all outstanding Class A shares not already owned by him for $5.30 per American Depositary Share (ADS). The company cautions that this proposal is preliminary, with no binding commitments made yet, and no decisions have been reached regarding the transaction. Shareholders are advised that no action is required at this time.

So-Young International Inc. (Nasdaq: SY) announced a non-binding proposal from CEO Xing Jin to acquire all outstanding Class A ordinary shares not owned by him for $5.30 per ADS or $6.89 per share in cash. This represents a premium of approximately 22.7% over the closing price on November 19, 2021. The company's board has formed a special committee of independent directors to evaluate the proposal, with no decisions made at this stage. There is no assurance that the acquisition will proceed, as it hinges on further negotiations and definitive agreements.

So-Young International Inc. (Nasdaq: SY) reported its third quarter 2021 financial results, achieving total revenues of RMB431.5 million (US$67.0 million), a 20.0% year-over-year increase. Net income surged 649.5% to RMB6.8 million (US$1.1 million), while non-GAAP net income rose 9.6% to RMB28.9 million (US$4.5 million). Despite a decline in average mobile MAUs to 8.0 million, the number of paying medical service providers grew 18.2% to 4,841. The Company anticipates fourth-quarter revenues between RMB430 million and RMB450 million, reflecting a potential increase of up to 6.0% compared to 2020.

So-Young International Inc. (NASDAQ: SY) will release its third-quarter financial results for the period ending September 30, 2021, before U.S. markets open on November 19, 2021. An earnings conference call will follow at 7:00 AM EST, with preregistration required due to COVID-19 restrictions. So-Young continues to position itself as a leader in China's medical aesthetics industry, offering a vibrant social community and reliable information to users.

So-Young International Inc. (SY) reported second quarter 2021 revenues of RMB451.8 million (US$70.0 million), up 37.7% from RMB328.2 million in Q2 2020, exceeding prior guidance. Net income reached RMB57.6 million (US$8.9 million), a 26-fold increase year-over-year, while non-GAAP net income grew by 145.2% to RMB73.7 million (US$11.4 million). Average monthly active users rose by 47.5% to 10 million, and paying medical service providers increased by 31.2% to 4,899. The company expects Q3 revenues between RMB430 million and RMB450 million, reflecting continued growth prospects despite potential COVID-19 impacts.

So-Young International Inc. (NASDAQ: SY) will release its financial results for Q2 ended June 30, 2021, before U.S. markets open on September 10, 2021. A management conference call will occur at 7:30 AM U.S. Eastern Time the same day. Due to COVID-19, operator-assisted calls are unavailable; preregistration is required. So-Young is a leading social community in China's medical aesthetics sector, providing reliable information and curated service providers, positioning itself for growth in both aesthetic and healthcare service markets.

So-Young International Inc. (Nasdaq: SY) announced its decision to acquire a controlling interest in Wuhan Miracle Laser Systems for a total of RMB 791 million. This acquisition is part of So-Young's strategy to capitalize on the growth potential in China's medical aesthetics industry, particularly in non-surgical segments. The transaction is expected to close in Q3 2021, subject to customary conditions. So-Young aims to leverage this acquisition to enhance its operational capabilities and provide greater returns to shareholders.

So-Young International Inc. (Nasdaq: SY) reported its financial results for Q1 2021, showing a 97.0% revenue increase to RMB359.6 million (US$54.9 million) compared to RMB182.6 million in Q1 2020. However, the company posted a net loss of RMB46.3 million (US$7.1 million), up from a net loss of RMB35.9 million a year earlier. Key operational metrics revealed an average mobile MAU increase of 101.0% to 8.4 million and a 123.3% rise in users purchasing reservation services. The company forecasts revenues between RMB430 million and RMB450 million for Q2 2021.